E
CDAK

Ergoteles’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Ergoteles’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,019
Closed -$30K – 2081
2022
Q3 		$30K Sell
38,019
-34,960
-48% -$27.6K ﹤0.01% 1466
2022
Q2 		$210K Buy
+72,979
New +$210K 0.01% 1300